Sepsis Indicators Parameters Provided by Sysmex Automated Hematology Analyzers: Streamlining Diagnosis and Therapy in Critically ill Patients
Early diagnosis of sepsis is a challenge for physicians because the success or failure of patient evolution is related to the fast recognition of the syndrome presence and the prompt therapeutic approach.
Sysmex XN-L analyzers are compact and suitable for laboratories that process small and medium volume samples. Some evaluations published in the literature reveal similar performance of the XN-L line when compared to XN analyzers. Learn about the characteristics of this Sysmex innovation and how it can be implement in your laboratory routine.
These are transformative times in the healthcare industry and especially for the clinical laboratory. Significant reimbursement
cuts and payment reform linked to quality measures are driving a new approach to laboratory testing. Laboratorians faced with a
changing business model and growing staff shortages are increasingly being asked to justify the value the laboratory provides.
The diagnosis of sepsis is complex due to the wide variety of nonspecific symptoms and the absence of a definitive diagnostic marker. Total and differential blood leukocyte counts are some of the tools used in the clinical investigation of sepsis. Laboratories can now report on the population of immature granulocytes with a high degree of accuracy through the Sysmex IG parameter, recognized as an infection / inflammation biomarker and an important indicator of sepsis
Taking on the challenges of the NEXT STAGE of urinalysis. Comparative evaluation of the analytical performance of UF-5000 and UF1000i analyzers